Search Results - Salvador CG

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis by Kongnakorn T, Sterchele JA, Salvador CG, Getsios D, Mwamburi M

    Published 2014
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: